Patent ID: 11970743
Assignee: DENDREON PHARMACEUTICALS LLC
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 3:
4. The method of claim 2, further comprising the step of steps of:
correlating (i) the first composite score of the biomarker expression product levels of SNTB1, SYNGR3, AURKC, ZNF268, and CHI3L2 of the patient and (ii) the PSA level, LDH level, Alkaline phosphatase level, Hemoglobin level, Total Gleason Score, and ECOG status to reference values of (i) and (ii) from mCRPC patients grouped into overall survival groups; and
classifying the patient into one of the overall survival groups based upon the patient's score relative to the reference values of (i) and (ii).